|
Aug 10
|
UPDATE 1-Obesity drug data could boost companies' case for US coverage-analysts
|
|
Aug 10
|
Obesity drug data could boost companies' case for US coverage-analysts
|
|
Aug 9
|
The Ozempic-killers already delivering fat profits
|
|
Aug 9
|
Eli Lilly Rises Again as Stock Upgraded Following Mounjaro Sales Surge
|
|
Aug 9
|
Only Four Days Left To Cash In On Eli Lilly's (NYSE:LLY) Dividend
|
|
Aug 9
|
UPS downgraded, Eli Lilly upgraded: Wall Street's top analyst calls
|
|
Aug 9
|
Eli Lilly Soars on Blockbuster Q2 Earnings: ETFs to Tap
|
|
Aug 9
|
More Alzheimer's Treatments Are Coming: This Company Can Help With Early Detection
|
|
Aug 9
|
Company News for Aug 9, 2023
|
|
Aug 9
|
Nektar Therapeutics (NKTR) Q2 Loss Narrows, Sales Miss
|
|
Aug 9
|
Lilly Completes Acquisition of DICE Therapeutics
|
|
Aug 9
|
Dow Jones Futures Rise After Market Rally Holds Support; Two Big AI Losers
|
|
Aug 9
|
Eli Lilly Has A Big Stake In Weight Loss And Alzheimer's Drugs; But Is The Stock A Buy?
|
|
Aug 9
|
China's Economic Woes, Crude Oil, Bond Auctions, Prime Day 2, Trading Lilly
|
|
Aug 9
|
Wall Street Analysts Are Bullish on These 10 Stocks with Increasing Price Targets
|